What is the current status of Imetelstat in clinical development?
Imetelstat is currently in various stages of clinical trials. Its most advanced trials are in the context of myelofibrosis and MDS, where it has received attention for its ability to produce durable responses in these patient populations. While it has not yet received regulatory approval for widespread clinical use, the data continues to support its potential role in cancer therapy, pending further validation and regulatory review.
